Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7545794

Concept As at
2023-06-30
2023-04-01 to
2023-06-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-06-30
As at
2022-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
177,189,000 JPY
794,621,000 JPY
156,456,000 JPY
Ordinary profit (loss)
13,517,000 JPY
-149,503,000 JPY
-54,731,000 JPY
Net assets
1,089,782,000 JPY
1,078,616,000 JPY
1,309,411,000 JPY
Total assets
1,427,121,000 JPY
1,434,337,000 JPY
1,649,544,000 JPY
Basic earnings (loss) per share
1.19
-31.10
-6.32
Diluted earnings per share
Equity-to-asset ratio
0.764 xbrli:pure
0.752 xbrli:pure
0.794 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.